Skip to main content
Journal cover image

ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR

Publication ,  Conference
Thompson, AJ; Santoro, R; Piazzolla, V; Tillman, HL; Patel, K; Clark, PJ; Naggie, S; Shianna, K; Mottola, L; Petruzzellis, D; Romano, M ...
Published in: HEPATOLOGY
October 1, 2010

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2010

Volume

52

Issue

4

Start / End Page

785A / 786A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thompson, A. J., Santoro, R., Piazzolla, V., Tillman, H. L., Patel, K., Clark, P. J., … Mangia, A. (2010). ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR. In HEPATOLOGY (Vol. 52, pp. 785A-786A). Boston, MA: WILEY-BLACKWELL.
Thompson, Alexander J., Rosanna Santoro, Valeria Piazzolla, Hans L. Tillman, Keyur Patel, Paul J. Clark, Susanna Naggie, et al. “ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR.” In HEPATOLOGY, 52:785A-786A. WILEY-BLACKWELL, 2010.
Thompson AJ, Santoro R, Piazzolla V, Tillman HL, Patel K, Clark PJ, et al. ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR. In: HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 785A-786A.
Thompson AJ, Santoro R, Piazzolla V, Tillman HL, Patel K, Clark PJ, Naggie S, Shianna K, Mottola L, Petruzzellis D, Romano M, Sogari F, Facciorusso D, Goldstein DB, McHutchison JG, Mangia A. ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR. HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 785A-786A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2010

Volume

52

Issue

4

Start / End Page

785A / 786A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics